日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Potential

揭示自泌素和溶血磷脂酸在阿尔茨海默病中的作用:从分子机制到治疗潜力

García-de Soto, Jesús; Castro-Mosquera, Mónica; Pouso-Diz, Jessica María; Fernández-Cabrera, Alejandro; Rodríguez-Arrizabalaga, Mariña; Debasa-Mouce, Manuel; Camino-Castiñeiras, Javier; Minguillón Pereiro, Anxo Manuel; Aramburu-Núñez, Marta; Romaus-Sanjurjo, Daniel; Aldrey, José Manuel; Pego-Reigosa, Robustiano; Pías-Peleteiro, Juan Manuel; Sobrino, Tomás; Ouro, Alberto

MonoPER study: Effectiveness and tolerability of PERampanel in monotherapy in real-world after 12 months of treatment

MonoPER 研究:真实世界中单药治疗 12 个月后 PERampanel 的有效性和耐受性

Fernández-Cabrera, Alejandro; Santamaría-Montero, Paula; García de-Soto, Jesús; Pego-Reigosa, Robustiano

EPIDEP: Prevalence of undiagnosed depression in an epilepsy outpatient clinic

EPIDEP:癫痫门诊中未确诊抑郁症的患病率

Fernández-Cabrera, Alejandro; Santamaría-Montero, Paula; Soto, Jesús García-de; Figueira-Gómez, Antía; Rodríguez-Botana, Martín; Pérez-Regojo, Benigno; Pego-Reigosa, Robustiano

[Usefulness of serological studies for the early diagnosis of Lyme disease in Primary Health Care Centres]

[血清学研究在基层医疗中心早期诊断莱姆病中的应用价值]

Vázquez-López, María Esther; Fernández, Gonzalo; Díaz, Pablo; Díez-Morrondo, Carolina; Pego-Reigosa, Robustiano; Coira-Nieto, Amparo

Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers

在缓解复发型多发性硬化症的干扰素β滴定阶段,不良事件的发生既不能通过体重指数预测,也不能通过药效学生物标志物预测。

Muñoz, Delicias; Escartín, Antonio; Dapena, Dolores; Coret, Francisco; Fernández-Uría, Dionisio; Pérez, Domingo; Casanova, Bonaventura; Guijarro-Castro, Cristina; Munteis, Elvira; del-Campo Amigo, María; Pego, Robustiano; Calles, Carmen; García-Rey, César; Monsalve, Nuria; Sánchez-Matienzo, David